Understanding heart disease risk in women who had preterm deliveries
Using Metabolomics to Understand CVD Risk in Women with a History of Preterm Delivery
This study is looking at how having a baby early might affect a woman's heart health later on, and it's for women who have experienced preterm delivery to help find ways to better protect their hearts.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10914017 on NIH RePORTER |
What this research studies
This research investigates the link between preterm delivery and the risk of cardiovascular disease (CVD) in women. By analyzing metabolic profiles, the study aims to uncover specific biological markers that could indicate a higher risk of CVD in these women. The research utilizes data and samples from large health studies to explore how different clinical characteristics of preterm delivery relate to cardiovascular health. Ultimately, the goal is to improve prevention and treatment strategies for CVD in women with a history of preterm delivery.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who have had a preterm delivery and are interested in understanding their cardiovascular health risks.
Not a fit: Patients who have not experienced preterm delivery or do not have concerns about cardiovascular disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better screening and preventive measures for cardiovascular disease in women who have experienced preterm delivery.
How similar studies have performed: Previous research has shown promising results in understanding cardiovascular risks through metabolic profiling, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Rexrode, Kathryn M — Brigham and Women's Hospital
- Study coordinator: Rexrode, Kathryn M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.